investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Center for Precision Medicine in Leukemia (CPML)
Mary V. Relling
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Hiroaki Mitsuya
Development of Novel Agents Active against Hepatitis B Virus
Leukaemia
Pathology
Daniel G Tenen
Mechanisms of regulation by RNA in acute myeloid leukemia
Leukaemia
Pathology
Robert G Roeder
Transcriptional Regulatory Mechanisms in B Cell Development and Leukemogenesis
Leukaemia
Pathology
Kevin A Goncalves
Role of Angiogenin in Hematopoietic Stem Cell Quiescence and Self-renewal
Leukaemia
Pathology
Alan Rein
Retrovirus Assembly and Maturation - Rockville
Leukaemia
Pathology
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Pathology
Vinay Pathak
Retroviral Replication and Interactions with Host Factors
Leukaemia
Pathology
Danilo Perrotti
Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival
Leukaemia
Pathology
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Pathology
